Clinical Trial Update: Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing cannabidivarin (CBDV) to placebo in children with autism spectrum disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Cannabidivarin (CBDV) (cannabidivarin)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Autism Spectrum Disorder | Phase 2 | Status: RECRUITING